Castle Biosciences, Inc.CSTLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P13
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -0.37% |
| 2024 | -2.94% |
| 2023 | 19.41% |
| 2022 | 51.46% |
| 2021 | 123.64% |
| 2020 | 79.50% |
| 2019 | 52.14% |
| 2018 | 8.52% |
| 2017 | 0.00% |